Zurück zur Übersicht
Huang, Huiying (2019) THE CCR5 CHEMOKINE RECEPTOR ANTAGONIST MARAVIROC EXERTS ANTI-NEOPLASTIC ACTIVITY IN PANCREATIC CANCER CELLS, WHICH MAY BE A NOVEL STRATEGY FOR TREATING METASTATIC PANCREATIC CANCER.